UK blood spot screening review highlights technical harmonisation drive
This article was originally published in Clinica
Diagnostic manufacturers and laboratories with an interest in newborn screening have an opportunity to participate in a UK review of the blood spot card. The card is a formal IVD device used to send the sample for testing at a lab; it also comprehensively records patient details and the test results.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.